Hematologic β-Tubulin VI Isoform Exhibits Genetic Variability That Influences Paclitaxel Toxicity
Luis J. Leandro‐García(Spanish National Cancer Research Centre), Cristina Rodríguez‐Antona(Instituto de Salud Carlos III), Sara Álvarez(Centro Nacional de Epidemiología), Aguirre A. de Cubas(Medical University of South Carolina), Iñigo Landa(Inserm), Susanna Leskelä(Spanish National Cancer Research Centre), José Rivera(Centro Regional de Hemodonación), Raúl Torres(Spanish National Cancer Research Centre), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Álvaro Gómez-Graña(Spanish National Cancer Research Centre), Lucía Inglada‐Pérez(Spanish National Cancer Research Centre), Alberto Cascón(Spanish National Cancer Research Centre), Marı́a Luisa Lozano(Universidad de Murcia), Iñaki Comino‐Méndez(Breast Cancer Now), Juan Carlos Ramírez(Spanish National Cancer Research Centre), Constantino Martı́nez(Centro Regional de Hemodonación), Agnieszka Maliszewska(Spanish National Cancer Research Centre), Rocío Letón
Cited by 24
Related Papers
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
|Cell Reports|2018|818
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
|Cancer Cell|2017|791
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
|Nature Genetics|2011|528
Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer
|JAMA Oncology|2019|425
Platelet receptors and signaling in the dynamics of thrombus formation
|Haematologica|2009|409